Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits.

Dermatology and Therapy
Mark LebwohlAbby Jacobson

Abstract

Psoriasis is a lifelong disease associated with cycles of remission and relapse. Topical treatments are the front line of psoriasis therapy for most patients and have antiproliferative, anti-inflammatory, and immunosuppressive mechanisms of action. Novel fixed-dose combinations of topical therapeutic agents are becoming increasingly available, leveraging multiple mechanisms of action to improve safety and efficacy with formulations that are easier to use and may allow for the use of lower doses of active ingredients. A fixed-combination lotion containing the potent-to-superpotent corticosteroid halobetasol propionate (HP) and the retinoid tazarotene (HP 0.01%/TAZ 0.045%) was recently developed using polymeric emulsion technology. This new formulation technology allows for more uniform and efficient delivery of the active ingredients at lower doses than conventional monotherapy formulations of either ingredient while providing enhanced hydration and moisturization. This review provides an up-to-date overview of the therapeutic mechanisms of action of HP and TAZ, the rationale behind the development of HP 0.01%/TAZ 0.045% lotion, and clinical trials data on the efficacy, safety and tolerability, and maintenance of therapeutic eff...Continue Reading

References

Oct 1, 1976·Postgraduate Medical Journal·M W Greaves
Apr 1, 1994·Journal of the American Academy of Dermatology·T Esgleyes-RibotM Duvic
Jan 1, 1994·Archives of Dermatological Research·C E Griffiths, J J Voorhees
Jan 13, 1995·The Journal of Biological Chemistry·S NagpalR A Chandraratna
Feb 1, 1996·Molecular and Cellular Biology·E Y TsaiA E Goldfeld
Jul 1, 1997·The Journal of Investigative Dermatology·S NagpalR A Chandraratna
Aug 15, 1998·Mediators of Inflammation·A Ahluwalia
Oct 20, 1998·Journal of the American Academy of Dermatology·M G LebwohlJ Sefton
Oct 20, 1998·Journal of the American Academy of Dermatology·M DuvicS Mays
Oct 27, 2001·International Journal of Dermatology·K KaidbeyJ R Gibson
Jan 31, 2002·American Journal of Clinical Dermatology·Benedetta Brazzini, Nicola Pimpinelli
Mar 23, 2004·Journal of the American Academy of Dermatology·Narin ApisarnthanaraxMadeleine Duvic
Aug 3, 2005·American Journal of Clinical Dermatology·Toni M Dando, Keri Wellington
Dec 31, 2005·Journal of the American Academy of Dermatology·Ulrich R HenggeMichael J Cork
Nov 1, 1990·The Journal of Investigative Dermatology·L E KingL B Nanney
Nov 30, 2007·Journal of Cellular Biochemistry·Takamasa NukuiNam-Ho Huh
May 21, 2008·Clinical Interventions in Aging·Stephanie OgdenChristopher E M Griffiths
Jul 22, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Buka SamtenPeter F Barnes
Dec 31, 2008·The Journal of Experimental Medicine·Cristina AlbanesiSilvano Sozzani
Jul 31, 2009·The New England Journal of Medicine·Frank O NestleJonathan Barker
Jul 30, 2010·The Journal of Dermatological Treatment·Jerry TanLinda Stein Gold
Aug 14, 2010·International Journal of Cosmetic Science·D RossettiC B Lin
Apr 18, 2012·Clinics in Dermatology·Ronni WolfVincenzo Ruocco
May 26, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·E CastelaJ P Ortonne
Aug 7, 2012·Expert Opinion on Drug Delivery·Xi TanRajesh Balkrishnan
Dec 6, 2012·International Journal of Endocrinology·Luís UvaPaulo Filipe
Aug 9, 2013·The Journal of Clinical Investigation·Shijin YinHongzhen Hu
Mar 7, 2014·The Journal of Investigative Dermatology·Tiffany M Scharadin, Richard L Eckert
Jan 15, 2015·Cytokine·Jaymie BaliwagAndrew Johnston
Jan 11, 2018·International Journal of Molecular Sciences·Andrea ChiricozziMarco Romanelli
Dec 18, 2018·Frontiers in Immunology·Woo Jae ShinRussell K Pachynski
Dec 20, 2018·Dermatology : International Journal for Clinical and Investigative Dermatology·Farida BenhadouVéronique Del Marmol
Feb 18, 2019·Journal of the American Academy of Dermatology·Alan MenterCraig A Elmets

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.